Seegnal eHealth
Prescription Operating System
Company Overview
Snapshot
Founded in September 2015, Seegnal eHealth operates with 11–50 employees. The company became public on TSXV in August 2025, following a qualifying transaction. Seegnal eHealth has secured funding across two public rounds and one private equity round, with Net Capital Ventures leading one of its private funding rounds.
Business overview
Seegnal eHealth provides a smart clinical decision-support platform designed to help clinicians manage and resolve patient-specific drug-related problems efficiently. Its core technology is a patented interface that integrates with electronic medical records and other relevant platforms, utilizing real-time algorithms and comprehensive pharmacological data from five global sources. The company serves the healthcare industry, aiming to improve patient care and safety, reduce healthcare expenditures, and mitigate alert fatigue and clinician burnout within clinical workflow and medical decision support sectors.
Strategic signal
In May 2026, Seegnal announced a Letter of Intent with a U.S.-based care facility, marking its initial entry into the American healthcare market. This strategic move signals a significant expansion opportunity for the company, indicating potential for increased market penetration and revenue growth in a key global healthcare market.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent strategic partnership for Seegnal eHealth?
- In June 2026, Seegnal was accepted into an innovative accelerator program from AARP, the largest U.S. organization serving Americans 50 and older. This partnership aims to advance the company's solutions for the senior demographic.
- What was a key product development for Seegnal eHealth in late 2025?
- In October 2025, Seegnal Inc. announced the release of its new "MetricsGuard" Clinical Decision Support Module, enhancing its platform's capabilities.
- What was a significant leadership change at Seegnal eHealth in late 2025?
- In November 2025, Seegnal Inc. announced the appointment of Elad Bibi-Aviv as its new Chief Executive Officer, signaling a change in the company's executive leadership.
- What was a notable market expansion for Seegnal eHealth in early 2026?
- In February 2026, Seegnal expanded the deployment of its Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a leading Israeli public medical center and global referral center.
- What was a recent operational development regarding Seegnal eHealth's financial reporting?
- In May 2026, Seegnal Inc. announced an update to the delay in filing its 2025 Annual Financial Statements and related Management Discussion and Analysis.